Burning Questions On 2-6
GPs face FGM challenge
End of life care - one chance to get it right
Prescribing antidepressants in pregnant women
Pain Management: Part 3
Cancer survivorship - The importance of ongoing care, Part 2
The role of SGLT2 inhibitors in Type 2 Diabetes
The advent of SGLT2 inhibitors, a new class of glucose lowering agent, currently represented by dapagliﬂozin (Forxiga)and canagliﬂozin (Invokana), offers a new mechanistic paradigm for treatment. Here, the authors consider the prescribing rationale and precautions, with an emphasis on the pharmacodynamic and kinetic properties of these agents.
Case discussion: Heavy menstrual bleeding in Primary Care and beyond
Heavy menstrual bleeding (HMB or menorrhagia) is a common complaint in primary care and the fourth most common reason for referral to gynaecological secondary care. Each year in England and Wales more than 30,000 women undergo surgical treatment for heavy menstruation.1 Here, the authors explore what can be learned from a typical case study.